Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 425 days ( -479.17 % )
Last Price $14.60 0 %
High/ Low $14.60 - $14.60 0%
Chg 7 Days N/A $14.60 $14.60
Chg 30 Days N/A $14.60 $14.60
Chg 12 mos N/A $14.60 $14.60
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos N/A Width: 0.00000000 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $14.60 - $14.60 0 % - 0 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 0000-00-00 - N/A days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Buy 2022-05-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Aduro Biotech

Aduro Biotech Aduro BioTech, Inc., a clinical-stage immunotherapy company, focuses on the discovery, development, and commercialization that transform the treatment of challenging diseases. Its lead product candidate is CRS-207, an immuno-oncology therapy, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer, unresectable malignant pleural mesothelioma, and ovarian cancer. The company also offers STING Pathway Activator prod... ADRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT